Are virtual meetings part of your coronavirus contingency plans?
ADVERTORIAL | Coronavirus has created worrying times around the world. As businesses set their coronavirus contingency plans, there are ways to ensure that pharma...
Impact and influence of technology in pharma recruitment
ADVERTORIAL | As online and digital technology advances, Pf talks with Andy Anderson at Evolve about the impact and influence of technology in pharma...
Shaping market opportunities to sell your solution
There is a challenge for new innovation to succeed. Nick Williams, explores how Triducive are shaping market opportunities to help you sell your solution In...
Pf Awards: The Olympics of the pharmaceutical industry
Pf Awards Judge Mark Pringle, on why he’s involved in the prestigious event. Tell me a little about yourself I’m an experienced executive coach, business...
Mapping the intricate oncology landscape
Simon Grime, of Wilmington Healthcare, explains how data and intelligence tools help pharma deliver tailored engagement programmes to diverse stakeholders in an intricate oncology...
Unpredictable times in pharma call for flexibility
Alan Kidd, a member of the CHASE Business Development team, looks how these unpredictable times in pharma call for flexibility, and how the industry...
Integrated commercial deployment in life sciences and other 2020 health trends
Syneos Health explore integrated commercial deployment in life sciences and discuss their new report covering 2020 health trends. Life science leaders aren’t launching with...
The quest for patient centricity
In the quest for patient centricity, pharmaceutical companies are working with a more extensive and increasingly diverse group of providers than ever before. Services...
How essential is digital engagement with HCPs?
Liz Murray and Nicolas Laurent on how digital engagement is essential in today’s tech-driven landscape. But could life sciences companies be doing better? Engagement between...
Mapping NHS change is key to customer engagement
Simon Grime, of Wilmington Healthcare, explains how mapping NHS change through data and intelligence can help industry understand and engage customers in the new...
Latest articles
Novartis’ Kisqali® shows overall survival benefit in advanced breast cancer
Novartis has announced a new exploratory subgroup analysis of the Phase III MONALEESA-3 and MONALEESA-7 trials, reinforcing the overall survival (OS) benefit of Kisqali®...
Pf Webinar: Adopting Agile in pharma for more effective cross-functional marketing teamwork
Pf is proud to announce the second instalment of the FREE webinar series with Triducive. This webinar focuses on Agile and how it can...
New Patient Recruitment Centres for late-phase clinical research
NHS patients will benefit from easier access to clinical research opportunities, following a £7m government investment to launch five new regional Patient Recruitment Centres...
Popular articles
Kate Bingham appointed Chair of UK Vaccine Taskforce
Kate Bingham has been appointed Chair of the UK’s Vaccine Taskforce – the group set up by the Government’s Chief Scientific Adviser, Deputy Chief...
BIVDA comments on Roche COVID-19 antibody test authorisation
The British In Vitro Diagnostics Association (BIVDA) has commented on the Roche COVID-19 antibody test authorisation by Public Health England. BIVDA is delighted to see...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
UPDATED: MHRA guidance on coronavirus (COVID-19)
The MHRA is producing guidance on coronavirus (COVID-19) for industry. The Medicines and Healthcare products Regulatory Agency (MHRA) is working closely with Department of Health...
Roche develops new COVID-19 antibody test
Roche has announced the development and upcoming launch of a new COVID-19 antibody test. Its Elecsys® Anti-SARS-CoV-2 serology test will detect antibodies in people...